Markel Corporation
NYSE:MKLInsurance - Property & Casualty
-$18.15 today
- Market cap
- $23.73B
- Beta
- 0.67
- P/E (TTM)
- 11.7
- EPS (TTM)
- $157.85
Volume 0.04M
Average 0.07M
MKL Capital Expenditures
Cash spent on property, plant, equipment, and other long-term assets.
Markel CorporationNYSE: MKL
Capital Expenditures · Q3 FY2026 · quarter ended Sep 2026
Capital expenditures growth accelerates
Q3 FY2026 capital expenditures of $96.54M (cash outflow) rose 84.2% year over year, ahead of the +15.4% change in trailing-twelve-month capital expenditures. Sequentially, it rose 117.8% from the prior quarter. Over 3 fiscal years it compounded at -6.7% a year.
Context
- Capital expenditures amounted to 1.2% of revenue in FY2025, down 0.3 pp from a year earlier.
- Capital expenditures grew in size in 1 of the last 3 fiscal years.
- FY2025 was the smallest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly growth of +84.2% holds above the trailing-twelve-month pace of +15.4%.
Sources:Cash FlowText generated from reported figures; not investment advice.
Capital Expenditures history
USD · from the cash flow
- Latest · FY2025
- (206.89M) USD
- Year-over-year change
- +18.9%
| Period | Period end | Capital Expenditures | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | (206.89M) | +18.9% |
| FY2024 | 2024-12-31 | (254.99M) | +1.4% |
| FY2023 | 2023-12-31 | (258.62M) | -1.5% |
| FY2022 | 2022-12-31 | (254.71M) | -75.4% |
| FY2021 | 2021-12-31 | (145.25M) | — |
Capital Expenditures vs competitors
How MKL compares with its peers on the latest reported figures
- MKL's LTM Sep 2026 capital expenditures of $251.25M is the largest of the 11 companies compared; the peer median is $12.51M.
- Its year-over-year change of +15.4% is the 3rd highest of 9, against a peer median of -39.9%.
- Capital expenditures amounts to 1.5% of revenue for MKL, versus a peer median of 0.3%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Sep 2026 | $251.25M | +15.4% | -6.7% | 1.5% | |
| LTM Jun 2026 | $135M | -290.1% | +16.2% | 1.7% | |
| LTM Jun 2026 | $121.35M | +89.8% | +47.8% | 0.7% | |
| LTM Sep 2026 | $88M | +190.7% | -1.2% | 0.3% | |
| LTM Sep 2026 | $74M | -22.9% | +18.3% | 0.5% | |
| LTM Jun 2026 | $45M | -2.2% | -5.2% | 0.2% | |
| LTM Sep 2026 | $23.24M | -56.9% | +98.1% | 1.2% | |
| LTM Sep 2026 | $1.79M | -58.0% | -2.1% | 0.1% | |
| LTM Jun 2026 | $0 | — | — | 0.0% | |
| LTM Sep 2026 | $0 | — | — | 0.0% | |
| LTM Sep 2026 | $0 | -100.0% | — | 0.0% | |
| Peer median (excluding MKL) | $12.51M | -39.9% | +16.2% | 0.3% | |
Competitors are the stored peer set for MKL. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | 2.45B | (101.2M) | 2.1B | 2.85B | 2.15B |
| Depreciation & Amortization | 336.39M | 309.45M | 319.73M | 342.36M | 347.92M |
| Deferred Income Tax | 453.41M | (281.75M) | 233.8M | 394.56M | 151.22M |
| Stock-Based Compensation | 0 | 0 | 0 | 0 | 0 |
| Change in Working Capital | 919.73M | 1.2B | 1.61B | 1.07B | 960.28M |
| Accounts Receivables | (1.68B) | (1.82B) | (1.25B) | 0 | (3.22B) |
| Inventory | 0 | 0 | 0 | 0 | 0 |
| Accounts Payables | 131.56M | 210.81M | 365.38M | 0 | 223.88M |
| Other Working Capital | 2.47B | 2.81B | 2.5B | 1.07B | 3.95B |
| Other Non-Cash Items | (1.88B) | 1.58B | (1.47B) | (2.06B) | (850.56M) |
| Operating Cash Flow | 2.27B | 2.71B | 2.79B | 2.59B | 2.76B |
| Capital Expenditures | (145.25M) | (254.71M) | (258.62M) | (254.99M) | (206.89M) |
| Acquisitions (Net) | (525.64M) | 752.33M | (155M) | (207.75M) | (106.21M) |
| Purchases of Investments | (3.42B) | (3.4B) | (4.94B) | (4.37B) | (4.27B) |
| Sales of Investments | 1.14B | 1.39B | 2.63B | 2.4B | 3.26B |
| Other Investing Activities | 16.21M | (161.09M) | 23.08M | 32.17M | 133.56M |
| Investing Cash Flow | (2.94B) | (1.67B) | (2.7B) | (2.4B) | (1.19B) |
| Debt Repayment | 711.78M | (220.95M) | (324.66M) | 537.46M | (29.45M) |
| Common Stock Issued | 0 | 0 | 0 | 0 | 0 |
| Common Stock Repurchased | (206.52M) | (290.8M) | (445.48M) | (572.73M) | (429.52M) |
| Dividends Paid | (36M) | (36M) | (36M) | (36M) | (618M) |
| Other Financing Activities | (99.49M) | (47.56M) | (193.57M) | (226.61M) | (133.08M) |
| Financing Cash Flow | 369.77M | (595.31M) | (999.72M) | (297.88M) | (1.21B) |
| Effect of Forex Changes | (41.73M) | (103.36M) | 27.04M | (37.3M) | 49.77M |
| Net Change in Cash | (335.7M) | 340.57M | (889.48M) | (139.79M) | 411.05M |
| Free Cash Flow | 2.13B | 2.45B | 2.53B | 2.34B | 2.55B |
Markel Corporation
NYSE:MKL
Intrinsic Alpha fair value
Locked
Current Price
$1,940.17
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.